Gynecologic cancer intergroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix

Kosei Hasegawa, Shoji Nagao, Masanori Yasuda, David Millan, Akila N. Viswanathan, Rosalind M. Glasspool, Mojgan Devouassoux-Shisheboran, Alan Covens, Domenica Lorusso, Christian Kurzeder, Jae Weon Kim, Laurence Gladieff, Jane Bryce, Michael Friedlander, Keiichi Fujiwara

Research output: Contribution to journalReview articlepeer-review

Abstract

Clear cell carcinomas of the uterine corpus and cervix are rare gynecological cancers with limited information regarding the pathogenesis and biology. At present, the approach to management is the same as for patients with the more common histological subtypes of endometrioid endometrial cancer and adenocarcinoma of the cervix. Surgical resection is the standard treatment for patients with early-stage disease, but there is no evidence-based approach to direct the management of patients with more advanced-stage disease at presentation or with recurrent disease. We review the epidemiology, pathology, and what is known about both uterine corpus and cervical clear cell cancers and make management recommendations.

Original languageEnglish (US)
Pages (from-to)S90-S95
JournalInternational Journal of Gynecological Cancer
Volume24
Issue number9
DOIs
StatePublished - Nov 2014
Externally publishedYes

Keywords

  • Clear cell carcinoma
  • Histological feature
  • Immunohistochemical
  • Treatment
  • Uterine cervix
  • Uterine corpus

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Gynecologic cancer intergroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix'. Together they form a unique fingerprint.

Cite this